Saved source record
Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study.
This is a source-metadata record last found in a complete check on Sep 29, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.
Study metadata
- Study type
- Original study
- Study category (metadata hint)
- Other or unclear
- Source date
- Published: 2026-09-03
- Authors
- Ren L, Zhang Y, Fang F, Ma Y.
- Journal or registry
- Not reported
- Registry study design
- Not reported
- Registry enrollment
- Not reported
- Funding agencies
- Pudong New District Health Technology Project; Shanghai Municipal Science and Technology Commission Project
- Identifiers
- DOI: 10.1111/dom.71303 · PMID: 42687799
- First found
- Sep 29, 2026
- Last found
- Sep 29, 2026
Original sources
Browse saved studies · Search live sources